PERSPECTA

News from every angle

← Back to headlines

Santen Pharmaceutical Reports Q1 GAAP EPS of ¥104.99

Santen Pharmaceutical Co. announced its Q1 GAAP EPS of ¥104.99 and revenue of ¥291.62 billion.

PostShare

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

seeking-alphaglg1h ago

Santen Pharmaceutical Co. Q1 GAAP EPS of ¥104.99, revenue of ¥291.62B

Read full article →

Related Stories

Amazon's First Customer Receipt Goes Viral, Bezos and Musk React

just now

Leni Robredo Launches Innovation Gateway in Naga City

just now

Sam Altman to Testify in Elon Musk's OpenAI Trial

just now

Nigerian Governors Clash Over Dangote Refinery and Performance

just now